ESLA: Estrella Immunopharma Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Estrella Immunopharma Inc (ESLA).

OverviewDividends

$38.20M Market Cap.

As of 09/28/2024 5:00 PM ET (MRY) • Disclaimer

ESLA Market Cap. (MRY)


ESLA Shares Outstanding (MRY)


ESLA Assets (MRY)


Total Assets

$4.45M

Total Liabilities

$180.70K

Total Investments

$0

ESLA Income (MRY)


Revenue

$0

Net Income

-$7.31M

Operating Expense

$7.31M

ESLA Cash Flow (MRY)


CF Operations

-$16.07M

CF Investing

$4.96M

CF Financing

$12.79M

ESLA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$4,454,189 (47.08%)

$3,028,399 (-68.86%)

$9,723,802 (182.62%)

$3,440,626

Assets Current

$4,454,189 (61.84%)

$2,752,212 (5149.61%)

$52,427 (287.83%)

$13,518

Assets Non-Current

$0 (0%)

$276,187 (-97.14%)

$9,671,375 (182.20%)

$3,427,108

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Shareholders Equity

$4,273,488 (136.39%)

-$11,742,550 (-420.58%)

-$2,255,685 (-11036.12%)

$20,626

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cash & Equivalents

$4,165,428 (68.02%)

$2,479,146 (5976.04%)

$40,802 (270.32%)

$11,018

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Investments

$0 (0%)

$273,066 (-97.18%)

$9,671,375 (203.18%)

$3,190,004

Investments Current

$0 (0%)

$273,066 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$9,671,375 (203.18%)

$3,190,004

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$0 (0%)

$9,333,146 (2735.39%)

$329,166 (0%)

$0

Accumulated Retained Earnings (Deficit)

-$19,500,276 (-59.99%)

-$12,188,553 (-440.31%)

-$2,255,827 (-51473.55%)

-$4,374

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$40,744 (0%)

$0 (0%)

$224,775 (0%)

$0

Total Debt

$0 (0%)

$0 (0%)

$498,600 (177.00%)

$180,000

Debt Current

$0 (0%)

$0 (0%)

$498,600 (177.00%)

$180,000

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Liabilities

$180,701 (-98.15%)

$9,770,949 (268.29%)

$2,653,041 (-22.43%)

$3,420,000

Liabilities Current

$180,701 (-98.15%)

$9,758,224 (809.38%)

$1,073,069 (366.55%)

$230,000

Liabilities Non-Current

$0 (0%)

$12,725 (-99.19%)

$1,579,972 (-50.47%)

$3,190,000

ESLA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0

Selling General & Administrative Expense

$3,201,173 (382.69%)

$663,190 (-51.53%)

$1,368,219 (394.90%)

$276,462

Research & Development Expense

$4,108,925 (-60.68%)

$10,451,212 (0%)

$0 (0%)

$457,231

Operating Expenses

$7,310,098 (-34.23%)

$11,114,402 (608.14%)

$1,569,527 (113.92%)

$733,693

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Income Tax Expense

$1,625 (0%)

$0 (0%)

$80,648 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$7,311,723 (34.21%)

-$11,114,402 (-1015.79%)

-$996,104 (-35.77%)

-$733,693

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$7,311,723 (34.21%)

-$11,114,402 (-1015.79%)

-$996,104 (-35.77%)

-$733,693

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$7,311,723 (34.21%)

-$11,114,402 (-1015.79%)

-$996,104 (-35.77%)

-$733,693

Weighted Average Shares

$27,103,964 (2034.10%)

$1,270,041 (-77.96%)

$5,762,911 (476.29%)

$1,000,000

Weighted Average Shares Diluted

$27,103,964 (2034.10%)

$1,270,041 (-77.96%)

$5,762,911 (476.29%)

$1,000,000

Earning Before Interest & Taxes (EBIT)

-$7,310,098 (34.23%)

-$11,114,402 (-1114.08%)

-$915,456 (-24.77%)

-$733,693

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0

Operating Income

-$7,310,098 (34.23%)

-$11,114,402 (-608.14%)

-$1,569,527 (-113.92%)

-$733,693

ESLA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$4,960,647 (1916.65%)

-$273,066 (-100.75%)

$36,170,124

-

Net Cash Flow from Financing

$12,793,941 (0%)

$0 (0%)

-$35,564,343

-

Net Cash Flow from Operations

-$16,068,306 (-1102.61%)

-$1,336,121 (-28.00%)

-$1,043,848

-

Net Cash Flow / Change in Cash & Cash Equivalents

$1,686,282 (204.79%)

-$1,609,187 (-267.34%)

-$438,066

-

Net Cash Flow - Business Acquisitions and Disposals

-$112,298 (58.88%)

-$273,066 (0%)

$0

-

Net Cash Flow - Investment Acquisitions and Disposals

$5,072,945 (0%)

$0 (0%)

$36,170,124

-

Capital Expenditure

$0 (0%)

$0 (0%)

$0

-

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$548,600

-

Issuance (Purchase) of Equity Shares

$4,572,615 (0%)

$0 (0%)

-$36,112,943

-

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0

-

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0

-

Share Based Compensation

$1,194,653 (191.67%)

$409,595 (0%)

$0

-

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0

-

ESLA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-91.70% (-151.75%)

177.20% (185.81%)

62.00%

-

Return on Average Assets (ROAA)

-58.60% (18.95%)

-72.30% (-1802.63%)

-3.80%

-

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

370.60% (421.14%)

-115.40% (-3018.92%)

-3.70%

-

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-3.89 (-213.88%)

-1.24 (97.35%)

-46.77

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

8.94 (265.52%)

-5.4 (79.76%)

-26.68

-

Debt to Equity Ratio (D/E)

0.04 (105.05%)

-0.83 (29.25%)

-1.18 (-100.71%)

165.81

Earnings Per Share (EPS)

-0.27 (96.91%)

-8.75 (-3877.27%)

-0.22 (99.97%)

-733.69

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0

Free Cash Flow Per Share (FCFPS)

-0.59 (43.63%)

-1.05 (-481.22%)

-0.18

-

Book Value Per Share (BVPS)

0.16 (101.71%)

-9.25 (-2264.71%)

-0.39 (-1961.90%)

0.02

Tangible Assets Book Value Per Share (TABVPS)

0.16 (-93.12%)

2.38 (41.32%)

1.69 (-50.97%)

3.44

Enterprise Value Over EBIT (EV/EBIT)

-5 (16.67%)

-6 (90.91%)

-66

-

Enterprise Value Over EBITDA (EV/EBITDA)

-4.58 (20.64%)

-5.77 (91.29%)

-66.22

-

Asset Turnover

0 (0%)

0 (0%)

0

-

Current Ratio

24.65 (8640.78%)

0.28 (475.51%)

0.05 (-16.95%)

0.06

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$16,068,306 (-1102.61%)

-$1,336,121 (-28.00%)

-$1,043,848

-

Enterprise Value (EV)

$33,467,818 (-47.80%)

$64,116,491 (5.77%)

$60,618,261

-

Earnings Before Tax (EBT)

-$7,310,098 (34.23%)

-$11,114,402 (-1114.08%)

-$915,456 (-24.77%)

-$733,693

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$7,310,098 (34.23%)

-$11,114,402 (-1114.08%)

-$915,456

-

Invested Capital

$108,060 (101.17%)

-$9,208,971 (-201.10%)

$9,108,531 (169.51%)

$3,379,608

Working Capital

$4,273,488 (161.00%)

-$7,006,012 (-586.43%)

-$1,020,642 (-371.47%)

-$216,482

Tangible Asset Value

$4,454,189 (47.08%)

$3,028,399 (-68.86%)

$9,723,802 (182.62%)

$3,440,626

Market Capitalization

$38,195,108 (-39.77%)

$63,410,748 (5.34%)

$60,193,413

-

Average Equity

$7,971,520 (227.07%)

-$6,273,421 (-290.60%)

-$1,606,115

-

Average Assets

$12,471,140 (-18.85%)

$15,368,430 (-41.94%)

$26,471,271

-

Invested Capital Average

-$1,972,662 (-120.49%)

$9,627,927 (-61.32%)

$24,892,992

-

Shares

36,376,293 (521.85%)

5,849,700 (0.00%)

5,849,700 (10.48%)

5,295,000